Abstract
We established a novel cancer cell line (MAST) from the ascitic fluid of a metastatic infiltrating ductal carcinoma of the breast. The epithelial and neoplastic nature of the MAST cells was confirmed by ultrastructural analysis. The cell line was maintained as a monolayer with a doubling time of about 68 h, and it possessed an abnormal karyotype with a modal chromosome number of 60, a trisomy of chromosome 18 and other unidentified rearranged chromosomes. Among the markers consistently found in MAST metaphases, we noted a t(14; 14) and a very large subtelocentric, a large satellited acrocentric and a very large submetacentric chromosome with striking fluorescent bands. Immunoenzymatic assay demonstrated that the MAST cell line was positive for estrogen and progesterone receptors. The in vitro drug-sensitivity assay showed a marked resistance of the cell line to 5-fluorouracil and 4-hydroperoxycyclophosphamide and a moderate resistance to etoposide and 4'-epidoxorubicin. The molecular analysis showed a four-to sixfold amplification of the c-myc gene and no amplification or rearrangement of the int-2, c-erbB-2, c-Ha-ras, c-mos and hst-1 genes.
References
Jan 1, 1975·Advances in Human Genetics·B Dutrillaux, J Lejeune
Nov 5, 1975·Journal of Molecular Biology·E M Southern
May 1, 1991·British Journal of Cancer·P MeltzerJ Trent
Aug 1, 1989·British Journal of Cancer·S MinafraD E Woolley
Jun 1, 1989·Current Opinion in Immunology·R Kath, M Herlyn
May 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·M TairaT Sugimura
Sep 6, 1985·Science·C R KingS A Aaronson
Feb 1, 1986·Molecular and Cellular Biology·G CaseyC Dickson
Jul 1, 1982·Proceedings of the National Academy of Sciences of the United States of America·R WatsonG F Vande Woude
Feb 25, 1983·Science·R Dalla-FaveraC M Croce
Jan 1, 1982·Journal of Cellular Biochemistry·S PulcianiM Barbacid
Mar 1, 1995·Genes, Chromosomes & Cancer·N PandisF Mitelman
Dec 30, 1994·Biochimica Et Biophysica Acta·P Devilee, C J Cornelisse
Mar 1, 1995·British Journal of Cancer·I ItoM Emi
Dec 1, 1993·Breast Cancer Research and Treatment·D AmadoriW Zoli
Jan 1, 1993·Advances in Cancer Research·M J van de Vijver
Citations
Aug 5, 1998·Cancer Genetics and Cytogenetics·W ZoliA Gasperi-Campani
Nov 11, 1998·Cancer Genetics and Cytogenetics·A Gasperi-CampaniD Amadori
Aug 26, 1998·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·A Gasperi-CampaniD Amadori
Apr 1, 1997·Breast Cancer Research and Treatment·W ZoliA Gasperi-Campani
Feb 6, 2004·Breast Cancer Research and Treatment·Marc Lacroix, Guy Leclercq
Oct 31, 2012·Cancer Cell International·Behnam KamalidehghanRozita Rosli
Dec 2, 2017·EMBO Molecular Medicine·Alessandro PecciAnna Savoia
May 20, 2017·Oncotarget·Hsiang-Ying LeeChien-Feng Li
Dec 10, 2016·Oncotarget·Peir-In LiangChien-Feng Li
Oct 27, 2016·Oncotarget·Wei-Ming LiWen-Jeng Wu
Oct 30, 2016·Oncotarget·Meng-Chen TsaiChien-Feng Li